Elizabeth is an industry veteran with over 20 years of dynamic, cross-functional leadership and advocacy development experience for our clients. Her market access and advocacy background has been shaped by a career at leading pharmaceutical and biotech companies, including Roche, Genentech, and Lilly. Elizabeth has helped bring more than 30 breakthrough products to market across various segments, such as rare diseases and specialty care. Her passion for creating pathways to improve outcomes for patients and providers is deeply rooted in her dedication to delivering effective, patient-centric market strategies for companies both large and small.
She is a skilled communicator and experienced community facilitator who leads peer-driven dialogues that empower patients and caregivers to shape meaningful research goals and effective post-launch market strategies. Elizabeth has designed, recruited for, and facilitated a variety of engagement programs aimed at uncovering and addressing the unique unmet needs of rare disease patient communities at local, national, and global levels.
Elizabeth specializes in patient advocacy, launch readiness, and cultivating key stakeholder alignment to drive the results that matter most to the patients they serve.